
Twenty years after rollout, HPV vaccination is central to global cancer control but far from finished
A new Nature Medicine comment argues that HPV vaccination has become a core part of the global cancer agenda, even as major delivery and equity challenges remain.
- A Nature Medicine comment says HPV vaccination is now central to global cancer control.
- The scientific case is established, but delivery and equity challenges remain substantial.







